S Sircar

429 total citations
17 papers, 360 citations indexed

About

S Sircar is a scholar working on Genetics, Molecular Biology and Cancer Research. According to data from OpenAlex, S Sircar has authored 17 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 10 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in S Sircar's work include Virus-based gene therapy research (12 papers), Viral Infectious Diseases and Gene Expression in Insects (5 papers) and Cancer Research and Treatments (4 papers). S Sircar is often cited by papers focused on Virus-based gene therapy research (12 papers), Viral Infectious Diseases and Gene Expression in Insects (5 papers) and Cancer Research and Treatments (4 papers). S Sircar collaborates with scholars based in Canada and United States. S Sircar's co-authors include Joseph Weber, Pascale Labrecque, Claudine Rancourt, Hossein Keyvani, Marcelo Teixeira Rodrigues, J Horváth, Laszlo Palkonyay, Witold Neugebauer, Patrick A. Dion and Cai Fang and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Virology and Journal of Cellular Physiology.

In The Last Decade

S Sircar

17 papers receiving 335 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
S Sircar	144	116	107	56	47	17	360
John B. Schell	115 0.8×	39 0.3×	230 2.1×	136 2.4×	59 1.3×	15	580
Wlodek Lopaczynski	152 1.1×	81 0.7×	174 1.6×	84 1.5×	20 0.4×	5	467
Shizhu Zang	241 1.7×	34 0.3×	35 0.3×	22 0.4×	27 0.6×	19	407
Matthew S. Lalonde	154 1.1×	17 0.1×	73 0.7×	31 0.6×	36 0.8×	13	478
Motohiro WATANABE	145 1.0×	43 0.4×	41 0.4×	57 1.0×	89 1.9×	11	411
Thomas Hudson	117 0.8×	34 0.3×	22 0.2×	24 0.4×	75 1.6×	12	484
Shuting Zhang	416 2.9×	35 0.3×	111 1.0×	65 1.2×	18 0.4×	44	745
Xiaowei Huo	202 1.4×	100 0.9×	22 0.2×	13 0.2×	46 1.0×	28	462
Arkadiusz Samojedny	296 2.1×	86 0.7×	26 0.2×	39 0.7×	30 0.6×	13	559
Hiroshi Kawamata	141 1.0×	18 0.2×	24 0.2×	37 0.7×	112 2.4×	15	490

Countries citing papers authored by S Sircar

Since Specialization

Citations

This map shows the geographic impact of S Sircar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Sircar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Sircar more than expected).

Fields of papers citing papers by S Sircar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Sircar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Sircar. The network helps show where S Sircar may publish in the future.

Co-authorship network of co-authors of S Sircar

This figure shows the co-authorship network connecting the top 25 collaborators of S Sircar. A scholar is included among the top collaborators of S Sircar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Sircar. S Sircar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Weber, Joseph, et al.. (2003). Inhibition of adenovirus infection and adenain by green tea catechins. Antiviral Research. 58(2). 167–173. 182 indexed citations

Sircar, S, et al.. (2000). The Effect of Mutant Peptide Cofactors on Adenovirus Protease Activity and Virus Infection. Virology. 270(1). 173–179. 12 indexed citations

Sircar, S, et al.. (2000). Adenovirus Endopeptidase Hydrolyses Human Squamous Cell Carcinoma Antigens in Vitro but not ex Vivo. Virology. 268(1). 141–146. 4 indexed citations

Sircar, S, et al.. (1998). Adenovirus endopeptidase and papain are inhibited by the same agents. Antiviral Research. 40(1-2). 45–51. 15 indexed citations

Allen, Cynthia M., et al.. (1996). New Stimulation Ligand of the Adenovirus 2 Protease. Virology. 224(2). 510–516. 3 indexed citations

Sircar, S, et al.. (1996). Inhibition of adenovirus infection with protease inhibitors. Antiviral Research. 30(2-3). 147–153. 14 indexed citations

Rancourt, Claudine, Hossein Keyvani, S Sircar, Pascale Labrecque, & Joseph Weber. (1995). Proline 137 Is Critical for Adenovirus Protease Encapsidation and Activation but Not Enzyme Activity. Virology. 209(1). 167–173. 51 indexed citations

Sircar, S, et al.. (1991). Transformation renders MDR cells more sensitive to polyunsaturated fatty acids.. PubMed. 10(6). 1783–6. 10 indexed citations

Sircar, S, et al.. (1991). Dominant suppression of adenovirus mediated transformation and insufficiency of p105Rb binding as a condition for oncogenic transformation.. PubMed. 6(6). 989–93. 3 indexed citations

10.

Rodrigues, Marcelo Teixeira, Patrick A. Dion, S Sircar, & Joseph Weber. (1990). Tumor necrosis factor mediated cytolysis requires the adenovirus E1A protein but not the transformed phenotype. Virus Research. 15(3). 231–236. 4 indexed citations

11.

Weber, Joseph, et al.. (1990). Drug-induced revertants of adenovirus-transformed cells: retransformation by 5-azacytidine without reactivation of E1a. Journal of General Virology. 71(3). 585–591. 3 indexed citations

12.

Weber, Joseph, S Sircar, J Horváth, & Patrick A. Dion. (1989). Non-p-glycoprotein-mediated multidrug resistance in detransformed rat cells selected for resistance to methylglyoxal bis(guanylhydrazone).. PubMed. 49(21). 5779–83. 11 indexed citations

13.

Sircar, S, et al.. (1989). Differential sensitivity of tumorigenic and genetically related non-tumorigenic cells to cytotoxic polyunsaturated fatty acids.. Anticancer Research. 9(4). 1049–52. 13 indexed citations

14.

Sircar, S & Joseph Weber. (1988). Normalization of epidermal growth factor receptor and transforming growth factor production in drug resistant variants derived from adenovirus transformed cells. Journal of Cellular Physiology. 134(3). 467–472. 4 indexed citations

15.

Sircar, S, et al.. (1988). Resistance to retransformation by adenovirus but not by heterologous oncogenes in an E1-positive transformation revertant cell line may be mediated by a cellular function.. PubMed. 3(6). 725–8. 5 indexed citations

16.

Rodrigues, Marcelo Teixeira, et al.. (1987). Isolation and uptake characteristics of adenovirus transformed cell revertants resistant to the antiproliferative effects of methylglyoxal bis(guanylhydrazone). Biochemical and Biophysical Research Communications. 147(2). 675–681. 8 indexed citations

17.

Sircar, S, et al.. (1987). Isolation of variants resistant to methylglyoxal bis(guanylhydrazone) from adenovirus-transformed rat cells.. PubMed. 47(5). 1339–43. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact